Diuretic inhibition of experimental myopia implicates retinal ion-driven efflux in the regulation of ocular growth
By
Melanie J. Murphy
Nina Riddell
David P. Crewther
Brian M. Ignacio
Sheila G. Crewther
May 11, 2026
Clinical Scorecard: Inhibition of Experimental Myopia by Diuretics Suggests Retinal Ion-Driven Fluid Efflux Plays a Role in Ocular Growth Regulation
At a Glance
Category Detail
Condition Myopia (short-sightedness) Key Mechanisms Retinal Ion-Driven fluid efflux from vitreous to choroid, influenced by diuretics affecting ion transport. Target Population Individuals at risk of myopia and associated ocular pathologies. Care Setting Clinical research and potential therapeutic management.
Key Highlights
Diuretics like furosemide and amiloride inhibit myopia development in response to negative lenses. Bumetanide and amiloride suppress hyperopia development in response to positive lenses. Retinal integrity maintained post-diuretic injection, indicating potential for therapeutic use. Guideline-Based Recommendations
Diagnosis
Monitor refractive errors using optical defocusing lenses in clinical settings. Management
Consider diuretic agents for controlling axial elongation in myopic patients. Monitoring & Follow-up
Regular assessment of ocular growth and refractive changes in patients using diuretics. Risks
Potential for severe sight-threatening pathologies in untreated myopia. Patient & Prescribing Data
Patients with myopia or at risk of developing myopia-related complications.
Diuretics may offer a novel approach to manage myopia through modulation of retinal fluid dynamics.
Clinical Best Practices
Evaluate the use of diuretics in conjunction with traditional myopia management strategies. Conduct further studies to establish long-term safety and efficacy of diuretics in myopia treatment. Related Resources & Content
